Support services for research on dangerous pathogens
NERBL Core 3: Biocontainment Research Support Services
['FUNDING_OTHER'] · TUFTS UNIVERSITY BOSTON · NIH-10910227
This study is all about making it safer and easier for scientists to work with germs that could cause serious illnesses, so they can better protect us from future outbreaks and help improve treatments for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TUFTS UNIVERSITY BOSTON (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10910227 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the safety and efficiency of studies related to pathogens that could cause pandemics and other emerging infections. It aims to provide specialized resources and training for researchers working with high-risk biological materials. By optimizing biocontainment facilities and developing standard procedures, the project seeks to support both academic and industry partners in their efforts to combat infectious diseases. Patients may benefit indirectly through improved medical countermeasures and knowledge gained from this research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk for infections caused by pathogens like Eastern Equine Encephalitis or Francisella tularemia.
Not a fit: Patients with non-infectious diseases or those not affected by emerging infectious pathogens may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better preparedness and response strategies for emerging infectious diseases, ultimately improving patient outcomes.
How similar studies have performed: Other research initiatives focused on biocontainment and pathogen response have shown success in enhancing safety and developing effective medical countermeasures.
Where this research is happening
BOSTON, UNITED STATES
- TUFTS UNIVERSITY BOSTON — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TELFORD, SAM R — TUFTS UNIVERSITY BOSTON
- Study coordinator: TELFORD, SAM R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.